GPP-A

Category

无分类内容

Summary: Synthesis of quinolone APIs such as levofloxacin, ofloxacin, ciprofloxacin, enrofloxacin, norfloxacin

Back to previous page Contact us

Detailed introduction

The company's 801 product and 1201 product have been applied individually or jointly to more than a dozen quinolone APIs such as ofloxacin, levofloxacin, ciprofloxacin, enrofloxacin and norfloxacin. With the extension of process substitution, follow-up will Apply to more quinolone APIs. In addition to the application of pharmaceutical intermediates, the company also expanded the application of 801 products to the field of pesticide intermediates, and used three major technology platforms to successfully develop new production processes for some pesticide intermediates and new material intermediates, replacing and transforming traditional processes , Began to enter the fields of pesticide fungicides, insecticides, herbicides, photoinitiators of new materials, and pharmaceutical cephalosporins, and the application of products and technology has gradually expanded.

Key words：Pharmaceutical intermediates, pesticide intermediates, new material intermediates

OPERATING LIMITS
• Suction lift up to 8m
• Clean water, non-corrosion liquid
• Fluid temperature up to 40 °C
• Maximum ambient temperature 40 °C

STRUCTURAL CHARACTERISTICS
• Brass impeller
• 100% Copper winding
• Single/Three-phase, 50/60Hz (as customized)
• Stainless steel mechanical seal (graphite to ceramic)
• Protection IP44
• C&U bearing or local bearing
• Thermal overload protector
• Anti-rust shaft (Hi-Cr plated or welded stainless steel)

PERFORMANCE DATA AT n=2900 rpm/min

Performance parameter

Model	Inlet/Outlet	Power		Q(m³/h)	0	0.6	1.2	1.8	2.4	3.6
Single phase	Inch	kW	HP	(L/mln)	0	10	20	30	40	60
GPP 600A	1"x1	0.6	0.8	H(m)	36	26	20	16	7	-
GPP 800A	1"x1	0.8	1.0		42	32	26	20	12	-
GPP 1100A	1"x1	1.1	1.5		47	38	31.5	28.5	24	9